Contraceptive Drugs Market Size, Share and Industry Analysis By Product Type (Oral, Injectable & Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs), and Regional Forecast 2018-2025

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Fertility Statistics - Key Countries, 2017

4.2 New Product Launch

4.3 Pipeline Analysis

4.4 Regulatory Scenario - Key Countries

4.5 Recent Industry Developments - Partnerships, Mergers & Acquisitions

5. Global Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings/Summary

5.2. Market Analysis, Insights and Forecast – By Product Type

5.2.1 Oral

5.2.1.1 Combined Contraceptives

5.2.1.2 Progestin-only Pills

5.2.2 Injectable

5.2.2 Patches

5.3. Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1 Hospital Pharmacy

5.3.2 Retail Pharmacy

5.3.3 Clinics

5.3.4 Online Channel

5.3.5 Public Channel & NGOs

5.3.6 Others

5.4. Market Analysis, Insights and Forecast – By Region

5.4.1 North America

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Latin America

5.4.5 Middle East & Africa

6. North America Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025

6.1. Key Findings/ Summary

6.2. Market Analysis – By Product Type

6.2.1 Oral

6.2.1.1 Combined Contraceptives

6.2.1.2 Progestin-only Pills

6.2.2. Injectable

6.2.3 Patches

6.3. Market Analysis – By Distribution Channel

6.3.1 Hospital Pharmacy

6.3.2 Retail Pharmacy

6.3.3 Clinics

6.3.4 Online Channel

6.3.5 Public Channel & NGOs

6.3.6 Others

6.4. Market Analysis – By Country

6.4.1 U.S

6.4.2 Canada

7. Europe Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025

7.1. Key Findings/ Summary

7.2. Market Analysis – By Product Type

7.2.1 Oral

7.2.1.1 Combined Contraceptives

7.2.1.2 Progestin-only Pills

7.2.2 Injectable

7.2.3 Patches

7.3. Market Analysis – By Distribution Channel

7.3.1 Hospital Pharmacy

7.3.2 Retail Pharmacy

7.3.3 Clinics

7.3.4 Online Channel

7.3.5 Public Channel & NGOs

7.3.6 Others

7.4. Market Analysis – By Countries/Sub regions

7.4.1 U.K

7.4.2 Germany

7.4.3 France

7.4.4 Italy

7.4.5 Spain

7.4.6 Scandinavia

7.4.7 Rest of Europe

8. Asia Pacific Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025

8.1. Key Findings/ Summary

8.2. Market Analysis – By Product Type

8.2.1 Oral

8.2.1.1 Combined Contraceptives

8.2.1.2 Progestin-only Pills

8.2.2 Injectable

8.2.3 Patches

8.3. Market Analysis – By Distribution Channel

8.3.1 Hospital Pharmacy

8.3.2 Retail Pharmacy

8.3.3 Clinics

8.3.4 Online Channel

8.3.5 Public Channel & NGOs

8.3.6 Others

8.4. Market Analysis – By Countries/Sub regions

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Southeast Asia

8.4.5 Australia

8.4.6 Rest of Asia Pacific

9. Latin America Contraceptive Drugs Market Analysis, Insights and Forecast,2014-2025

9.1. Key Findings/ Summary

9.2. Market Analysis – By Product Type

9.2.1 Oral

9.2.1.1 Combined Contraceptives

9.2.1.2 Progestin-only Pills

9.2.2 Injectable

9.2.3 Patches

9.3. Market Analysis – By Distribution Channel

9.3.1 Hospital Pharmacy

9.3.2 Retail Pharmacy

9.3.3 Clinics

9.3.4 Online Channel

9.3.5 Public Channel & NGOs

9.3.6 Others

9.4. Market Analysis – By Countries/Sub regions

9.4.1 Brazil

9.4.2 Mexico

9.4.3 Rest of Latin America

10. Middle East & Africa Contraceptive Drugs Market Analysis, Insights and Forecast, 2014-2025

10.1. Key Findings/Summary

10.2. Market Analysis – By Product Type

10.2.1 Oral

10.2.1.1 Combined Contraceptives

10.2.1.2 Progestin-only Pills

10.2.2 Injectable

10.2.3 Patches

10.3. Market Analysis – By Distribution Channel

10.3.1 Hospital Pharmacy

10.3.2 Retail Pharmacy

10.3.3 Clinics

10.3.4 Online Channel

10.3.5 Public Channel & NGOs

10.3.6 Others

10.4. Market Analysis – By Countries/Sub regions

10.4.1 South Africa

10.4.2 GCC

10.4.3 Rest of Middle East & Africa

11. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2017)

11.3. Competition Dashboard

11.4. Comparative Analysis – Major Players

11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

11.5.1 Bayer AG

11.5.2 Pfizer Inc.

11.5.3 Janssen Global Services, LLC

11.5.4 Teva Pharmaceutical Industries Ltd.

11.5.5 Merck & Co., Inc.

11.5.6 Mylan N.V.

11.5.7 Allergan

11.5.8 HLL Lifecare Limited

11.5.9 Piramal Enterprises Ltd.

11.5.10 Other Prominent Players

12. Strategic Recommendations